Introduction: Female hyperandrogenism is essentially manifested
by hirsutism. It is present in Senegal but not yet elucidated for lack of data.
This is why we proposed to study the profile of hyperandrogenism in our
context. Patients and Methods: This was an observational,
cross-sectional cohort study of 19 patients of reproductive age followed for
hyperandrogenism at the Medical Clinic II of Abass Ndao Hospital, from November
1st, 2019 to August 31st, 2021. Results: Our cohort consisted of
women with an average age of 25.3 years, single (73.7%), with a low
socioeconomic level (42.1%). A family history of hirsutism was found in 31.6%
of cases. The main reasons for consultation were a menstrual cycle disorder in
94.7% of cases, and hirsutism in 78.9% of cases. The latter was post-pubertal
(66.7%), with a slow or progressive evolution. The physical examination
revealed: hirsutism (100%) with an average modified Ferriman Gallwey score (mFG)
of 8.9 ± 5.8, acne (36.8%), hyperseborrhea (57.9%), major signs of virilization
(10.5%), acanthosis nigricans (47.4%) and galactorrhea (5.3%). Hormonal
explorations revealed an elevation of: testosterone (31.6%),
17-hydroxyprogesterone (5.3%), dihydrotestosterone (31.6%), and prolactin (10.5%). The ovarian morphology was
micropolycystic (84.2%). The etiological profile corresponded to polycystic ovarian
syndrome or PCOS (68.4%), ovarian hyperthecosis (10.5%), hyperprolactinemia
(10.5%), congenital adrenal hyperplasia or CAH (5.3%). Idiopathic hirsutism was
found in 5.3% of cases. Conclusion: Female hyperandrogenism is a less
frequent reason for consultation in endocrinology. It deserves to be further
evaluated in a large-scale study focused on epidemiological, clinico-biological
and etiological investigation, in order to assess its prevalence and better
define its profile in our context.
References
[1]
Peigné, M., Villers-Capelle, A., Robin, G. and Dewailly, D. (2013) Hyperandrogénie féminine. La Presse Médicale, 42, 1487-1499. https://doi.org/10.1016/j.lpm.2013.07.016
[2]
Azziz, R., Woods, K.S., Reyna, R., et al. (2004) The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population. The Journal of Clinical Endocrinology & Metabolism, 89, 2745-2749. https://doi.org/10.1210/jc.2003-032046
[3]
Asunción, M., Calvo, R.M., San Millán, J.L., et al. (2000) A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain. The Journal of Clinical Endocrinology & Metabolism, 85, 2434-2438.
[4]
Li, R., Qiao, J., Yang, D., et al. (2012) Epidemiology of Hirsutism among Women of Reproductive Age in the Community: A Simplified Scoring System. European Journal of Obstetrics & Gynecology and Reproductive Biology, 163, 165-169. https://doi.org/10.1016/j.ejogrb.2012.03.023
[5]
Escobar-Morreale, H.F., Carmina, E., Dewailly, D., et al. (2012) Epidemiology, Diagnosis and Management of Hirsutism: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Human Reproduction Update, 18, 146-170. https://doi.org/10.1093/humupd/dmr042
[6]
Azziz, R., Sanchez, L.A., Knochenhauer, E.S., et al. (2004) Androgen Excess in Women: Experience with over 1000 Consecutive Patients. The Journal of Clinical Endocrinology & Metabolism, 89, 453-462. https://doi.org/10.1210/jc.2003-031122
[7]
Reingold, S.B. and Rosenfield, R.L. (1987) The Relationship of Mild Hirsutism or Acne in Women to Androgens. Archives of Dermatological Research, 123, 209-212. https://doi.org/10.1001/archderm.123.2.209
[8]
Bachelot, A., Catteau-Jonard, S., Chabbert-Buffet, N., et al. (2020) Nouvelles recommandations pour le traitement des hyperandrogénies. SFE.
[9]
Bachelot, A., Catteau-Jonard, S., Chabbert-Buffet, N., et al. (2020) Nouvelles recommandations pour le traitement des hyperandrogénies de la SFE. Society For Education.
[10]
Nacer, K.M. (2011) L’hirsutisme en Algérie: étude étiologique. Annales de Dermatologie et de Vénéréologie, 138, A277. https://doi.org/10.1016/j.annder.2011.10.362
[11]
Aynaou, H., Elilie Mawa Ongoth, F. and Latrech, H. (2017) Profil clinique et étiologique de l’hyperandrogénie chez la femme au CHU Mohammed VI d’Oujda. Annales d'Endocrinologie, 78, 366. https://doi.org/10.1016/j.ando.2017.07.490
[12]
Carmina, E., Rosato, F., Jannì, A., Rizzo, M. and Longo, R.A. (2006) Extensive Clinical Experience: Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred Because of Clinical Hyperandrogenism. The Journal of Clinical Endocrinology & Metabolism, 91, 2-6. https://doi.org/10.1210/jc.2005-1457
[13]
Dewailly, D., Hieronimus, S., Mirakian, P. and Hugues, J.N. (2010) Le syndrome des ovaires polymicrokystiques (SOPMK). Annales d'Endocrinologie, 71, e9-e14. https://doi.org/10.1016/j.ando.2009.12.004
[14]
Parlak, M., Parlak, A.E. and Toslak, I.E. (2016) Etiologic Factors and Clinical Characteristics of Turkish Adolescent Girls Diagnosed with Hirsutism. Journal of Clinical and Analytical Medicine, 7, 205-209.
[15]
Laassara, W. (2017) Profil métabolique des patientes ayant une hyperandrogénie (A propos de 92 cas). Thèse de doctorat, Université Sidi Mohamed Ben Abdallah, Fès.
[16]
Puri, N. (2012) A Study on the Clinical and Hormonal Profile of Patients with Hirsutism. Our Dermatol Online, 3, 88-91. https://doi.org/10.7241/ourd.20122.18
[17]
Hatch, R., Rosenfield, R.L., Kim, M.H. and Tredway, D. (1981) Hirsutism: Implications, Etiology, and Management. American Journal of Obstetrics and Gynecology, 140, 815-830. https://doi.org/10.1016/0002-9378(81)90746-8
[18]
Mokni, S., Hammami, H., et al. (2011) Caractéristiques épidémio-cliniques, facteurs de risque, étiologies de l’hirsutisme: à propos de 84 cas. Annales de Dermatologie et de Vénéréologie, 138, A168. https://doi.org/10.1016/j.annder.2011.10.113
[19]
Catteau-Jonard, S., Proust-Richard, C., Robin, G., et al. (2013) Hyperandrogénie chez l’adolescente. Encycl Méd Chir, Gynécologie, 802-A-36.
[20]
Sharma, N.L., Mahajan, V.K., Jindal, R., Gupta, M. and Lath, A. (2008) Hirsutism: Clinico-Investigative Profile of 50 Indian Patients. Indian Journal of Dermatology, 53, 111-114. https://doi.org/10.4103/0019-5154.42387
[21]
Aziouaz, F., Bensbaa, S., Damoune, I., Yassine, I. and Ajdi, F. (2013) Hirsutisme: Aspects Cliniques, Biologiques et étiologiques (à propos de 20 cas). Annales d’Endocrinologie, 74, 316-317. https://doi.org/10.1016/j.ando.2013.07.254
[22]
James, W.D. (2005) Acne. The New England Journal of Medicine, 352, 1463-1472. https://doi.org/10.1056/NEJMcp033487
[23]
Mahajan, V.K., Singh Chauhan, P., Chandel, M., et al. (2021) Clinico-Investigative Attributes of 122 Patients with Hirsutism: A 5-Year Retrospective Study from India. International Journal of Women’s Dermatology, 7, 237-242. https://doi.org/10.1016/j.ijwd.2020.11.007
[24]
Déchaud, H., Raverot, V., Plotton, I. and Pugeat, M. (2012) Stratégie d’exploration des hyperandrogénies. In: Letombe, B., Catteau-Jonard, S. and Robin, G., Eds., Endocrinologie en gynécologie et obstétrique, Elsevier Masson, Paris, 129-138. https://doi.org/10.1016/B978-2-294-70154-2.00011-X
[25]
Liu, K., Motan, T. and Claman, P. (2017) No 350-Hirsutisme: évaluation et traitement. Journal of Obstetrics and Gynaecology Canada, 39, 1069-1084. https://doi.org/10.1016/j.jogc.2017.08.012
[26]
Droumaguet, C., Salenave, S., Brailly-Tabard, S. AND Young, J. (2010) Hyperandrogénie et hirsutisme. EMC (Elsevier Masson SAS, Paris), Endocrinologie, Nutrition, 10.033-G-10.
[27]
Azziz, R., Carmina, E., Chen, Z., et al. (2016) Polycystic Ovary Syndrome. Nature Reviews Disease Primers, 2, Article No. 16057. https://doi.org/10.1038/nrdp.2016.57
[28]
Lizneva, D., Suturina, L., Walker, W., et al. (2016) Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome. Fertility and Sterility, 106, 6-15. https://doi.org/10.1016/j.fertnstert.2016.05.003